4//SEC Filing
RESPONSE BIOMEDICAL CORP 4
Accession 0001437749-15-010863
CIK 0000806888operating
Filed
May 20, 8:00 PM ET
Accepted
May 21, 7:05 PM ET
Size
5.8 KB
Accession
0001437749-15-010863
Insider Transaction Report
Form 4
Kinnaird-Steen Barbara
Vice President
Transactions
- Award
Stock Option (Right to Buy)
2015-05-19+150,000→ 150,000 totalExercise: $0.72Exp: 2025-05-19→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Exercise prices shown are denominated in Canadian dollars.
- [F2]25% of 50,000 options shall vest and become exercisable on May 19, 2016, and 1/48th of these 50,000 options shall vest over the next 36 months commencing on the first day of each calendar month beginning June 1, 2016, subject to the reporting person's continued employment with the Company through each vesting date. The next 50,000 options shall vest at the time of the Company's release of its financial results for the year ended December 31, 2015, upon the achievement of certain corporate objectives for fiscal year 2015, as determined by the Company's board. The remaining 50,000 options shall vest at the time of the Company's release of its financial results for the year ended December 31, 2016, upon the achievement of certain corporate objectives for fiscal year 2016, as determined by the Company's board.
Documents
Issuer
RESPONSE BIOMEDICAL CORP
CIK 0000806888
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0000806888
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 7:05 PM ET
- Size
- 5.8 KB